SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Key Financials
Net Income
$-11721669
↓ 28.2%
Operating Income
$-11916824
↓ 54.8%
Cash & Equivalents
$334005.00
↓ 82.6%
Total Assets
$10.5M
↑ 318.0%
EPS (Diluted)
$-7.16
↓ 117.0%
Total Liabilities
$8.2M
↑ 357.5%
Shareholders' Equity
$2.3M
↑ 217.9%
Operating Cash Flow
$-9481645.00
↓ 29.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 9/24/2026 | View on SEC |
| 8-K/A | 9/24/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 8-K | 9/11/2026 | View on SEC |
| DEFA14A | 9/2/2026 | View on SEC |
| 8-K | 9/2/2026 | View on SEC |
| 8-K | 9/1/2026 | View on SEC |
| 8-K | 8/28/2026 | View on SEC |
| NT 10-Q | 8/17/2026 | View on SEC |
| 8-K/A | 8/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SHPH |
| Company Name | Shuttle Pharmaceuticals Holdings, Inc. |
| CIK | 1757499 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (240) 403-4212 |